| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/05/1997 | EP0759781A1 Method for treating and preventing atherosclerosis |
| 03/05/1997 | EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/05/1997 | EP0759768A1 Vasoactive intestinal polypeptide |
| 03/05/1997 | EP0759752A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 03/05/1997 | EP0759742A1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use |
| 03/05/1997 | CN1144529A Heterocyclic compounds, their preparation and use |
| 03/05/1997 | CN1144522A Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 03/05/1997 | CN1144489A Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 03/05/1997 | CN1144487A Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives |
| 03/05/1997 | CN1144483A Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives |
| 03/05/1997 | CN1144482A Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 03/05/1997 | CN1144480A Guanylhydrazones for treating inflammatory conditions |
| 03/05/1997 | CN1144091A Compounds having retinoid-like activity |
| 03/05/1997 | CN1034171C 4-pyrimdinone derivatives, their preparation and their application in therapy |
| 03/04/1997 | US5608084 And vascular pathologies; multistep preparation by reacting a hydroquinone with alkyl vinyl ketone, esterifying hydroxy 3,4-dihydro-2h-1-benzopyran, demethylating ether, reacting with alkyl 5-bromopentanoate, hydrolyzing, two more steps |
| 03/04/1997 | US5608075 Polymorphs of losartan and the process for the preparation of form II of losartan |
| 03/04/1997 | US5608045 Disodium salt by pot reacting rhamnose triacetate with phenyl dichlorophosphate in presence of triethylamine and with /s/leu-/s/trp-oet in solvent, saponifying separated product with ethanolic base in cold, evaporating ethanol |
| 03/04/1997 | US5607978 Prostaglandins for vision defects |
| 03/04/1997 | US5607976 Substituted benzenesulfonyl-thioureas and pharmaceutical preparations containing them |
| 03/04/1997 | US5607962 Substituted indole derivatives |
| 03/04/1997 | US5607958 Neurotensin receptor binders |
| 03/04/1997 | US5607957 Containing also indole, benzofuran, benzthiophene or indazole moiety; method for treatment and/or prevention of clinical conditions for which a selective agonist of 5-ht1-like receptors is indicated |
| 03/04/1997 | US5607956 1-heteroazolyl-1-heterocyclyl alkane derivatives and their use and their use as neuroprotective agents |
| 03/04/1997 | US5607949 Vasocontrictors, treating migrain |
| 03/04/1997 | US5607944 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparations |
| 03/04/1997 | US5607943 Cardioprotective, cerebroprotective, antiinflammatory agents |
| 03/04/1997 | US5607938 Medicament for treating or preventing cerebrovascular infarction |
| 03/04/1997 | US5607935 Treating stroke and cerebral ischemia |
| 03/04/1997 | US5607931 1,2-disubstituted ethly amides as inhibitors of ACAT |
| 02/27/1997 | WO1997007334A1 Axial flow valve system for linear compressor |
| 02/27/1997 | WO1997007120A1 Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists |
| 02/27/1997 | WO1997006816A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 02/27/1997 | WO1997006814A1 Method of promoting angiogenesis |
| 02/27/1997 | WO1997006813A1 Mucosal preparation containing physiologically active peptide |
| 02/27/1997 | WO1997006805A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 02/27/1997 | WO1997006802A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 02/27/1997 | WO1997006796A1 Benzothiophene compounds |
| 02/27/1997 | WO1997006794A1 Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine |
| 02/27/1997 | WO1997006791A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 02/27/1997 | WO1997003188A3 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | CA2229450A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 02/27/1997 | CA2226735A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 02/26/1997 | EP0759434A1 Benzothiophene compounds |
| 02/26/1997 | EP0759297A1 Remedy for pulmonary heart |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0758899A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
| 02/26/1997 | EP0758897A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 02/26/1997 | EP0758892A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
| 02/26/1997 | EP0705266B1 Process for producing imidazole derivative |
| 02/26/1997 | EP0630382B1 Lactam dipeptides having hle inhibiting activity |
| 02/26/1997 | EP0587819B1 Medetomidine preparations for transdermal administration |
| 02/26/1997 | CN1143963A Tetracyclic derivatives, process of preparation and use |
| 02/26/1997 | CN1143950A Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/26/1997 | CN1143644A N-|(1,4-diazadicyclo |2,2,2¨ oct -2-yl methyl¨ benzoic amide derivatives, its preparing process and medicinal use |
| 02/26/1997 | CN1143632A Fluorine-containing benzoylguanidines |
| 02/26/1997 | CN1143497A Method of treating cardiac inflammatory disease |
| 02/26/1997 | CN1034123C Calcium channel blocking polypeptides from filistate hibernalis |
| 02/26/1997 | CA2184052A1 Piperidinylmethyloxazolidinones |
| 02/25/1997 | US5606062 Stereoselective reduction |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605924 Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophenes |
| 02/25/1997 | US5605902 5-HT2 receptor antagonist compositions useful in treating venous conditions |
| 02/25/1997 | US5605891 Administering glycosaminoglycans |
| 02/25/1997 | US5605821 Expression control sequences of the P-selectin gene |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | US5605696 Drug loaded polymeric material and method of manufacture |
| 02/25/1997 | CA2183937A1 Alkenyl-benzoylguanidine derivatives |
| 02/25/1997 | CA2049514C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 02/25/1997 | CA2046146C Pyrrole derivatives |
| 02/25/1997 | CA2030396C 5-[1-(imidazol)methyl]-3,3-disubstituted-2(3h)furanone derivatives |
| 02/25/1997 | CA1338937C Process for the manufacture of novel substituted alkanediphosphonic acids |
| 02/25/1997 | CA1338934C 3-aminomethyl derivatives of indane, indoline and ¬dihydro-benzo|-furane and thiophene |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997006168A1 1,9-diazabicyclo[4.3.0]nona-3,8-diene derivatives |
| 02/20/1997 | WO1997006155A1 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen-1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof |
| 02/20/1997 | WO1997005878A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005877A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005868A1 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
| 02/20/1997 | WO1996040081A3 Oral delivery of gene constructs |
| 02/20/1997 | CA2512366A1 Mammalian iap gene family, primers, probes and detection methods |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2228843A1 1- 2-(2,3-dihydro-1h-inden-1-yl)ethyl -4-(naphth-1-yl) piperazine derivatives, their preparation and their application in therapeutics |
| 02/20/1997 | CA2228136A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2228050A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2221729A1 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
| 02/19/1997 | EP0758650A1 Endothelin receptor antagonists |
| 02/19/1997 | EP0758648A1 Substituted 4H-pyrans with a modulating effect on calcium channels |
| 02/19/1997 | EP0758647A1 Acyl substituted aminopyrans with a modulating effect on calcium channels |
| 02/19/1997 | EP0758644A1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives |
| 02/19/1997 | EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 02/19/1997 | EP0758390A1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/19/1997 | EP0758330A1 Biphenylcarboxamides useful as 5-ht1d antagonists |
| 02/19/1997 | EP0758312A1 Substituted fused and bridged bicyclic compounds as therapeutic agents |
| 02/19/1997 | EP0758247A1 O-desulfated heparin derivatives, methods of making and uses thereof |
| 02/19/1997 | EP0758246A1 Pharmaceutical composition comprising hyaluronic acid for the clearing of arteriosclerosis |
| 02/19/1997 | EP0758243A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa |